Form 4: TransDigm Group Director Acquires Shares in Lieu of Fees

Sentiment:

SEC Form 4 Filing


Director Jane M. Cronin acquired 31 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 22, 2024.

Summary

  • On March 22, 2024, Jane M. Cronin, a director of TransDigm Group INC, acquired 31 shares of common stock.
  • The acquisition was made in lieu of a semi-annual director fee, as part of the Director Share Plan.
  • The price of the stock was $1,172.2 per share.
  • Following the transaction, Ms. Cronin directly owns 586.62 shares of TransDigm Group INC.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a routine transaction indicating director alignment with shareholder interests. There are no indications of negative performance or concerns.

Positives

  • The director's acquisition of shares demonstrates confidence in the company's value.

Industry Context

Directors receiving stock in lieu of fees is a common practice to align their interests with shareholders and conserve company cash.

Comparison to Industry Standards

  • Director compensation practices vary across the aerospace industry, but equity-based compensation is a common component.
  • Comparing TransDigm's director compensation structure to peers like Boeing, Lockheed Martin, and RTX Corporation would provide further context.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders by aligning director interests with theirs.

Key Dates

DateDescription
03/22/2024Date of transaction: Director acquired shares in lieu of fee.
03/26/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.